LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · IEX Real-Time Price · USD
5.50
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
5.54
+0.04 (0.73%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
LifeStance Health Group Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for LFST stock have an average target of 9.00, with a low estimate of 8.00 and a high estimate of 10. The average target predicts an increase of 63.64% from the current stock price of 5.50.
Analyst Consensus: Buy
* Price targets were last updated on Apr 22, 2024.
Analyst Ratings
The average analyst rating for LFST stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Buy Reiterates $10 | Buy | Reiterates | $10 | +81.82% | Apr 22, 2024 |
Jefferies | Jefferies | Strong Buy Maintains $8 → $9 | Strong Buy | Maintains | $8 → $9 | +63.64% | Mar 6, 2024 |
Goldman Sachs | Goldman Sachs | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +63.64% | Mar 4, 2024 |
Goldman Sachs | Goldman Sachs | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | +45.45% | Nov 22, 2023 |
JP Morgan | JP Morgan | Hold Maintains $10 → $8 | Hold | Maintains | $10 → $8 | +45.45% | Nov 17, 2023 |
Financial Forecast
Revenue This Year
1.25B
from 1.06B
Increased by 17.94%
Revenue Next Year
1.41B
from 1.25B
Increased by 12.85%
EPS This Year
-0.26
from -0.51
EPS Next Year
-0.21
from -0.26
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 1.3B | 1.5B | 1.7B |
Avg | 1.2B | 1.4B | 1.6B |
Low | 1.2B | 1.3B | 1.5B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 22.6% | 19.6% | 18.2% |
Avg | 17.9% | 12.9% | 12.9% |
Low | 12.8% | 5.9% | 7.7% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.22 | -0.17 | -0.07 |
Avg | -0.26 | -0.21 | -0.15 |
Low | -0.28 | -0.25 | -0.17 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.